BAXTER/GENETICS INSTITUTE’s RECOMBINATE ANTIHEMOPHILIC FACTOR APPROVED BY FDA DEC. 10; FIRST LICENSED rFACTOR VIII PRODUCT WILL BEGIN SHIPPING DEC. 21

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".